Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis

Clinical trial NCT04853368 · TERMINATED

Trial details

NCT number: NCT04853368
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis (CF)

Start date: 2021-09-20
Primary completion: 2023-06-05
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.